KLOW is an extended version of our GLOW blend, adding the anti-inflammatory tripeptide KPV to the same regenerative base — totalling 80 mg of active peptide content:
- GHK-Cu – 50 mg
- BPC-157 – 10 mg
- TB-500 (Thymosin Beta-4 fragment) – 10 mg
- KPV – 10 mg
The addition of KPV is intended for research protocols examining inflammation-modulating pathways (NF-κB signalling) alongside the tissue-repair and extracellular matrix research already associated with the GLOW base compounds. As with all Marvix Peptides blends, each component is also individually available for researchers who prefer to study compounds separately.
